Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             66 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adverse Health Outcomes 3 Years after Radical Prostatectomy Compared with Men in the General Population: A Study from the Cancer Registry of Norway Nilsson, Mona

22 6 p.
artikel
2 Age Does Not Impact Cancer Specific Mortality: From Sub-Distributional and Cause-Specific Hazard Analysis in RCC Patients Undergoing Radical Nephrectomy and Thrombectomy Kim, Younjuong

22 6 p.
artikel
3 Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial Carcinoma Xu, Vincent E.

22 6 p.
artikel
4 Appearance of New Lesions Associate With Poor Prognosis in Pembrolizumab-Treated Urothelial Carcinoma Hara, Takuto

22 6 p.
artikel
5 A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder Liveringhouse, Casey

22 6 p.
artikel
6 Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor Bakaloudi, Dimitra Rafailia

22 6 p.
artikel
7 Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study Grivas, Petros

22 6 p.
artikel
8 Can Patients With Urogenital Cancer Rely on Artificial Intelligence Chatbots for Treatment Decisions? Erkan, Anil

22 6 p.
artikel
9 Characteristics of Abdominal Fat Based on CT Measurements to Predict Early Recurrence After Initial Surgery of NMIBC in Stage Ta/T1 Yu, Nengfeng

22 6 p.
artikel
10 Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer McKenzie, Jane

22 6 p.
artikel
11 Clinical, Prognosis, and Treatment Effect Features Analysis of Metachronous and Synchronous UTUC and BUC Zuo, Wei

22 6 p.
artikel
12 Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching Kobayashi, Keita

22 6 p.
artikel
13 Comparison of Industry-Sponsored Trials (IST) and Investigator-Initiated Trials (IIT) in Advanced Genitourinary Cancers in the United States, Canada, United Kingdom and France Wong, Bryan

22 6 p.
artikel
14 Concordance Between the Expert Reading of Biparametric-MRI and the Nonexpert Multiparametric-MRI for the Detection of Clinically Significant Prostate Cancer: Clinical Implications Paesano, Nahuel

22 6 p.
artikel
15 Detection of Apical Cancer with Novel Imaging Modalities to Predict Apical Margin Positivity in Robotic Assisted Radical Prostatectomy Wagaskar, Vinayak G.

22 6 p.
artikel
16 Development and Validation of a Nomogram for Predicting Postoperative Recurrence-Free Survival in Patients With Nonmetastatic Pathological T3a Stage Renal Cell Carcinoma Li, Xintao

22 6 p.
artikel
17 Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study Reike, Moritz J.

22 6 p.
artikel
18 Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS—Meet-URO 26 Real-World Study Patrikidou, Anna

22 6 p.
artikel
19 Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors Xiang, Jenny J

22 6 p.
artikel
20 Efficacy and Safety of Combination AKT and Androgen Receptor Signaling Inhibition in Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis Nahar, Tulika A.K.

22 6 p.
artikel
21 Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study Guida, Annalisa

22 6 p.
artikel
22 Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis Maddah, Mohammad Moein

22 6 p.
artikel
23 Exploring Radiotherapy as a Promising Alternative for Managing Advanced Upper Tract Urothelial Carcinoma: Rescuing Chemotherapy-Intolerant Patients Liu, Ming-Zhu

22 6 p.
artikel
24 Fatigue Management in Advanced Prostate Cancer: Real-World Insights From Qualitative Interviews With Patients Freedland, Stephen J.

22 6 p.
artikel
25 High Sensitivity Circulating Tumor-DNA Assays in Renal Cell Carcinoma–Are we there yet? Sidhom, Fady

22 6 p.
artikel
26 Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer Qian, Zhiyu

22 6 p.
artikel
27 Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer Tural, Deniz

22 6 p.
artikel
28 Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY Trial Chappidi, Meera R.

22 6 p.
artikel
29 Impact of Urethra-Preserving Surgery During Radical Cystectomy: An Optimal Urethral Management in the Robotic Era Zennami, Kenji

22 6 p.
artikel
30 Landscape of Genomic Profiling and Circulating Tumor DNA Among Rare Genitourinary Cancers Kazarian, Austin G

22 6 p.
artikel
31 Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection Baky, Fady

22 6 p.
artikel
32 Markers in Identifying Pathological Complete Response Status in Muscle Invasive Bladder Cancer Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy Piao, Chengri

22 6 p.
artikel
33 Metastatic Prostate Cancer: Sequential or Combination Therapy? Dottorini, Lorenzo

22 6 p.
artikel
34 National Trends in PSA Cancer Screening With Parallel Investigation of Colorectal Cancer Screening: An Analysis of the CDC Behavioral Risk Factor Surveillance System From 2012 to 2022 Nguyen, Anh

22 6 p.
artikel
35 NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma Saitta, Cesare

22 6 p.
artikel
36 Nomograms to Appraise The Risk of Chronic Kidney Disease After Radical Cystectomy: Shifting The Focus to Prevention Artiles Medina, Alberto

22 6 p.
artikel
37 Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database Moldovan, Matthew

22 6 p.
artikel
38 Outcomes of Radical Radiotherapy for the Treatment of Localized Renal Pelvic and Ureteral Carcinoma Intolerant to Surgery: A Real-World Study Liu, Ming-Zhu

22 6 p.
artikel
39 Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma Nicaise, Edouard H.

22 6 p.
artikel
40 Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab Ornstein, Moshe C.

22 6 p.
artikel
41 Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer Obasi, Jennifer

22 6 p.
artikel
42 Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Kardoust Parizi, Mehdi

22 6 p.
artikel
43 Prognostic Impact of Bone Metastasis in Patients With Metastatic Urothelial Carcinoma Treated With Durvalumab With or Without Tremelimumab in the DANUBE Study Stecca, Carlos

22 6 p.
artikel
44 Prognostic Nomogram, Demographics and Comparative Analysis of Urinary Bladder Small Cell and Large Cell Neuroendocrine Carcinoma Ullah, Asad

22 6 p.
artikel
45 Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance Perera, Marlon

22 6 p.
artikel
46 Quantitative Investigation of MicroRNA-32 in the Urine of Prostate Cancer Patients and Its Relationship With Clinicopathological Characteristics Mahdizade, Amir Hossein

22 6 p.
artikel
47 Rare type of Bellini Duct Carcinoma in a Patient With Cacchi–Ricci Disease: A Case Report and Mini-Review Franco, Antonio

22 6 p.
artikel
48 Real-life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel – A multicentric Study From Portugal Botelho, Francisco

22 6 p.
artikel
49 Real-world Efficacy and Safety of Low-Dose Abiraterone With Food and Standard-Dose Abiraterone in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Analysis Do, Tu Anh

22 6 p.
artikel
50 Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study Liontos, M.

22 6 p.
artikel
51 RETRACTED: Roles of Long Noncoding RNA in Prostate Cancer Pathogenesis Zhao, Tongyue

22 6 p.
artikel
52 Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer Scilipoti, Pietro

22 6 p.
artikel
53 Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database Zerdan, Maroun Bou

22 6 p.
artikel
54 Safety Analysis of Co-Administration of Radiation Therapy with Enfortumab Vedotin Based Regimens in Metastatic Urothelial Carcinoma Seyedin, S.N.

22 6 p.
artikel
55 Salvage Stereotactic Radiotherapy for Nodal Oligo-Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Aman, Ayesha

22 6 p.
artikel
56 Serum Androgens as Predictive Biomarkers: Results From a Randomized Clinical Trial Comparing Enzalutamide and Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer Ternov, Klara K.

22 6 p.
artikel
57 Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study Bakaloudi, Dimitra Rafailia

22 6 p.
artikel
58 Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis O'Dwyer, Richard

22 6 p.
artikel
59 Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial Carcinoma Zappia, Jason

22 6 p.
artikel
60 Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles Chakraborty, Anumita

22 6 p.
artikel
61 The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART) Chakrani, Zakaria

22 6 p.
artikel
62 The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis Tsuboi, Ichiro

22 6 p.
artikel
63 The Impact of Radical Prostatectomy Versus Radiation Therapy on Cancer-Specific Mortality for Nonmetastatic Prostate Cancer: Analysis of an Other-Cause Mortality Matched Cohort Finati, Marco

22 6 p.
artikel
64 Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale Sternberg, Cora N.

22 6 p.
artikel
65 Treatment Patterns and Survival Outcomes Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer Narayan, Vivek

22 6 p.
artikel
66 Urachal Carcinoma: Insights From a National Database Orsini, Angelo

22 6 p.
artikel
                             66 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland